|
|
|
Insider
Information: |
Ho Carole |
Relationship: |
Chief Medical Officer |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
143,605 |
|
Indirect Shares
|
208,219 |
|
|
Direct
Value |
$2,961,135 |
|
|
Indirect Value
|
$4,293,476 |
|
|
Total
Shares |
351,824 |
|
|
Total
Value |
$7,254,611 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
13
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
11
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
30.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-08-21 |
4 |
D |
$18.59 |
$52,671 |
D/D |
(2,834) |
49,684 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-12-19 |
4 |
AS |
$20.00 |
$51,320 |
D/D |
(2,566) |
4,324 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-12-20 |
4 |
AS |
$20.00 |
$17,200 |
D/D |
(860) |
3,464 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-12-23 |
4 |
AS |
$20.01 |
$69,315 |
D/D |
(3,464) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-03-30 |
4 |
S |
$19.48 |
$27,817 |
D/D |
(1,428) |
2,822 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,643 |
8,465 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-08-21 |
4 |
D |
$32.88 |
$64,248 |
D/D |
(1,954) |
6,511 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-09-10 |
4 |
AS |
$31.00 |
$114,359 |
I/I |
(3,689) |
165,141 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-10-08 |
4 |
AS |
$40.12 |
$918,989 |
I/I |
(22,906) |
166,617 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-10-08 |
4 |
OE |
$5.28 |
$120,944 |
I/I |
22,906 |
189,523 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-10-09 |
4 |
AS |
$40.68 |
$1,236,614 |
I/I |
(30,000) |
166,617 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2020-10-09 |
4 |
OE |
$5.28 |
$158,400 |
I/I |
30,000 |
196,617 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-02-07 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,250 |
169,391 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-02-09 |
4 |
S |
$74.40 |
$109,785 |
I/I |
(1,470) |
167,921 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-02-11 |
4 |
S |
$70.17 |
$221,972 |
I/I |
(3,156) |
172,233 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-03-01 |
4 |
AS |
$64.54 |
$470,741 |
I/I |
(7,092) |
165,141 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-03-29 |
4 |
AS |
$54.62 |
$154,126 |
I/I |
(2,822) |
162,319 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-08-19 |
4 |
S |
$49.31 |
$126,230 |
I/I |
(2,546) |
164,773 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-08-23 |
4 |
AS |
$48.91 |
$300,454 |
I/I |
(6,143) |
158,630 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2021-12-06 |
4 |
AS |
$42.52 |
$62,760 |
D/D |
(1,476) |
76,316 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
107,316 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-01-05 |
4 |
S |
$44.78 |
$127,399 |
I/I |
(2,845) |
163,285 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-02-09 |
4 |
S |
$37.10 |
$52,791 |
I/I |
(1,423) |
166,112 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-02-11 |
4 |
S |
$34.71 |
$101,284 |
I/I |
(2,918) |
170,663 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2022-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
110,597 |
0 |
- |
|
108 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|